St. Jude Medical's (STJ) BurstDR Receives FDA Approval

October 4, 2016 8:31 AM EDT Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) announced U.S. approval of BurstDRā„¢ stimulation, a physician-designed form of spinal cord stimulation (SCS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login